{"transactions":[{"id":4635288,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41247,"kind":"person","name":"Higuchi John W.","position":1,"cik":"0001579891","reported_name":"Higuchi John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-10-02T04:28:21.000Z","date":"2026-09-30","kind":"purchase","planned":false,"acquired":true,"shares":15970,"price":2.23,"value":35613.1,"ownership":{"direct":true},"balance_after":241365,"source":{"system":"sec-edgar","filing":"0001493152-26-045400","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226045400/ownership.xml","form_type":"4"}},{"id":4635287,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41247,"kind":"person","name":"Higuchi John W.","position":1,"cik":"0001579891","reported_name":"Higuchi John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-10-02T04:28:21.000Z","date":"2026-09-29","kind":"purchase","planned":false,"acquired":true,"shares":9037,"price":2.15,"value":19429.55,"ownership":{"direct":true},"balance_after":225395,"source":{"system":"sec-edgar","filing":"0001493152-26-045400","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226045400/ownership.xml","form_type":"4"}},{"id":4635289,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41247,"kind":"person","name":"Higuchi John W.","position":1,"cik":"0001579891","reported_name":"Higuchi John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-10-01T04:38:30.000Z","date":"2026-09-28","kind":"purchase","planned":false,"acquired":true,"shares":12561,"price":2.16,"value":27131.76,"ownership":{"direct":true},"balance_after":216358,"source":{"system":"sec-edgar","filing":"0001493152-26-045185","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226045185/ownership.xml","form_type":"4"}},{"id":693118,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":25460,"kind":"person","name":"Grissinger Michael","position":1,"cik":"0001757601","reported_name":"Grissinger Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-07T20:11:15.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":2.11,"value":4220.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of August 3, 2027, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorata basis over the following two years."}],"balance_after":2000,"derivative":{"exercise_price":2.11,"exercise_date":"2027-08-03","expiration_date":"2036-08-03","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001493152-26-036577","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757601/000149315226036577/ownership.xml","form_type":"4"}},{"id":722615,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-30T23:31:08.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":52781,"price":2.49,"value":131424.69,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on June 29, 2027 while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years."}],"balance_after":227214,"derivative":{"exercise_price":2.49,"exercise_date":"2027-06-29","expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":52781},"source":{"system":"sec-edgar","filing":"0001493152-26-031377","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226031377/ownership.xml","form_type":"4"}},{"id":749263,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41247,"kind":"person","name":"Higuchi John W.","position":1,"cik":"0001579891","reported_name":"Higuchi John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2026-06-04T20:05:24.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":2.19,"value":3863.16,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting upon one year from date of grant."}],"balance_after":13290,"derivative":{"exercise_price":2.19,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001493152-26-027262","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226027262/ownership.xml","form_type":"4"}},{"id":749264,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41248,"kind":"person","name":"Jene Jill M.","position":1,"cik":"0001742105","reported_name":"Jene Jill M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-04T20:05:23.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":2.19,"value":3863.16,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant."}],"balance_after":8938,"derivative":{"exercise_price":2.19,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001493152-26-027261","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226027261/ownership.xml","form_type":"4"}},{"id":749262,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2026-06-04T20:05:20.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":2.19,"value":3863.16,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant."}],"balance_after":13290,"derivative":{"exercise_price":2.19,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001493152-26-027259","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226027259/ownership.xml","form_type":"4"}},{"id":813162,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41247,"kind":"person","name":"Higuchi John W.","position":1,"cik":"0001579891","reported_name":"Higuchi John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-04-07T22:27:25.000Z","date":"2026-04-07","kind":"purchase","planned":false,"acquired":true,"shares":40000,"price":2.03,"value":81200.0,"ownership":{"direct":true},"balance_after":203797,"source":{"system":"sec-edgar","filing":"0001493152-26-015583","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226015583/ownership.xml","form_type":"4"}},{"id":814265,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41247,"kind":"person","name":"Higuchi John W.","position":1,"cik":"0001579891","reported_name":"Higuchi John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-04-06T23:01:22.000Z","date":"2026-04-06","kind":"purchase","planned":false,"acquired":true,"shares":123000,"price":2.05,"value":252150.0,"ownership":{"direct":true},"balance_after":163797,"source":{"system":"sec-edgar","filing":"0001493152-26-015361","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226015361/ownership.xml","form_type":"4"}},{"id":814266,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2026-04-06T22:33:10.000Z","date":"2026-04-06","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":2.03,"value":50750.0,"ownership":{"direct":true},"balance_after":160679,"source":{"system":"sec-edgar","filing":"0001493152-26-015357","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226015357/ownership.xml","form_type":"4"}},{"id":819026,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2026-04-02T21:05:58.000Z","date":"2026-04-02","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":2.02,"value":50500.0,"ownership":{"direct":true},"balance_after":135679,"source":{"system":"sec-edgar","filing":"0001493152-26-014959","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226014959/ownership.xml","form_type":"4"}},{"id":950292,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-05T20:50:00.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":8,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on January 2, 2027, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years."}],"balance_after":182668,"derivative":{"exercise_price":8,"exercise_date":"2027-01-02","expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-26-000361","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226000361/ownership.xml","form_type":"4"}},{"id":961862,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-19T22:09:42.000Z","date":"2025-12-18","kind":"grant","planned":false,"acquired":true,"shares":8629,"price":4.2,"value":36241.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on December 18, 2026, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years."}],"balance_after":157668,"derivative":{"exercise_price":4.2,"exercise_date":"2026-12-18","expiration_date":"2035-12-18","underlying":"Common Stock","underlying_shares":8629},"source":{"system":"sec-edgar","filing":"0001493152-25-028597","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315225028597/ownership.xml","form_type":"4"}},{"id":961863,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":71078,"kind":"person","name":"Fogarty Krista","position":1,"cik":"0001906986","reported_name":"Fogarty Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-19T22:07:29.000Z","date":"2025-12-18","kind":"grant","planned":false,"acquired":true,"shares":20786,"price":4.2,"value":87301.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on December 18, 2026, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years."}],"balance_after":40146,"derivative":{"exercise_price":4.2,"exercise_date":"2026-12-18","expiration_date":"2035-12-18","underlying":"Common Stock","underlying_shares":20786},"source":{"system":"sec-edgar","filing":"0001493152-25-028593","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315225028593/ownership.xml","form_type":"4"}},{"id":1120954,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2025-06-05T20:07:01.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":3.2,"value":5644.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant."}],"balance_after":11526,"derivative":{"exercise_price":3.2,"exercise_date":"2026-06-04","expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001641172-25-013796","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000164117225013796/ownership.xml","form_type":"4"}},{"id":1120953,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41248,"kind":"person","name":"Jene Jill M.","position":1,"cik":"0001742105","reported_name":"Jene Jill M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T20:06:49.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":3.2,"value":5644.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant."}],"balance_after":7174,"derivative":{"exercise_price":3.2,"exercise_date":"2026-06-04","expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001641172-25-013795","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000164117225013795/ownership.xml","form_type":"4"}},{"id":1120952,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":75908,"kind":"person","name":"Papapetropoulos Spyros","position":1,"cik":"0001832694","reported_name":"Papapetropoulos Spyros","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T20:06:40.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":3.2,"value":5644.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant."}],"balance_after":7174,"derivative":{"exercise_price":3.2,"exercise_date":"2026-06-04","expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001641172-25-013797","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000164117225013797/ownership.xml","form_type":"4"}},{"id":1120951,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2025-06-05T20:06:29.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":3.2,"value":5644.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting upon one year from date of grant."}],"balance_after":11526,"derivative":{"exercise_price":3.2,"exercise_date":"2026-06-04","expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001641172-25-013793","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000164117225013793/ownership.xml","form_type":"4"}},{"id":1120950,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41247,"kind":"person","name":"Higuchi John W.","position":1,"cik":"0001579891","reported_name":"Higuchi John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2025-06-05T20:06:21.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":3.2,"value":5644.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting upon one year from date of grant."}],"balance_after":11526,"derivative":{"exercise_price":3.2,"exercise_date":"2026-06-04","expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001641172-25-013794","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000164117225013794/ownership.xml","form_type":"4"}},{"id":1318336,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-03T00:47:51.000Z","date":"2024-12-23","kind":"grant","planned":false,"acquired":true,"shares":10320,"price":4.8,"value":49536.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on December 23, 2025, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years."}],"balance_after":132688,"derivative":{"exercise_price":4.8,"exercise_date":"2025-12-23","expiration_date":"2034-12-23","underlying":"Common Stock","underlying_shares":10320},"source":{"system":"sec-edgar","filing":"0001493152-25-000123","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315225000123/ownership.xml","form_type":"4/A","original_submission_date":"2024-12-30"}},{"id":1318335,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-03T00:46:47.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":16371,"price":4.86,"value":79563.06,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on January 2, 2026, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years."}],"balance_after":149039,"derivative":{"exercise_price":4.86,"exercise_date":"2026-01-02","expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":16371},"source":{"system":"sec-edgar","filing":"0001493152-25-000121","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315225000121/ownership.xml","form_type":"4"}},{"id":1320303,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-31T01:04:57.000Z","date":"2024-12-23","kind":"grant","planned":false,"acquired":true,"shares":26691,"price":4.8,"value":128116.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on December 23, 2025, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years."}],"balance_after":149039,"derivative":{"exercise_price":4.8,"exercise_date":"2025-12-23","expiration_date":"2034-12-23","underlying":"Common Stock","underlying_shares":26691},"source":{"system":"sec-edgar","filing":"0001493152-24-052577","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315224052577/ownership.xml","form_type":"4"}},{"id":1320302,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":71078,"kind":"person","name":"Fogarty Krista","position":1,"cik":"0001906986","reported_name":"Fogarty Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-31T01:03:01.000Z","date":"2024-12-23","kind":"grant","planned":false,"acquired":true,"shares":5943,"price":4.8,"value":28526.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on December 23, 2025, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years."}],"balance_after":19460,"derivative":{"exercise_price":4.8,"exercise_date":"2025-12-23","expiration_date":"2034-12-23","underlying":"Common Stock","underlying_shares":5943},"source":{"system":"sec-edgar","filing":"0001493152-24-052575","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315224052575/ownership.xml","form_type":"4"}},{"id":1486209,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":75908,"kind":"person","name":"Papapetropoulos Spyros","position":1,"cik":"0001832694","reported_name":"Papapetropoulos Spyros","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T21:48:20.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":7.05,"value":12436.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant."}],"balance_after":5410,"derivative":{"exercise_price":7.05,"exercise_date":"2025-06-05","expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001493152-24-023215","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315224023215/ownership.xml","form_type":"4"}},{"id":1486208,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2024-06-07T21:45:33.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":7.05,"value":12436.2,"ownership":{"direct":true},"balance_after":10938,"derivative":{"exercise_price":7.05,"exercise_date":"2025-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001493152-24-023213","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315224023213/ownership.xml","form_type":"4"}},{"id":1486206,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41248,"kind":"person","name":"Jene Jill M.","position":1,"cik":"0001742105","reported_name":"Jene Jill M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T21:43:25.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":7.05,"value":12436.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant."}],"balance_after":5410,"derivative":{"exercise_price":7.05,"exercise_date":"2025-06-05","expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001493152-24-023211","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315224023211/ownership.xml","form_type":"4"}},{"id":1486207,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41247,"kind":"person","name":"Higuchi John W.","position":1,"cik":"0001579891","reported_name":"Higuchi John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2024-06-07T21:41:45.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":7.05,"value":12436.2,"ownership":{"direct":true},"balance_after":10938,"derivative":{"exercise_price":7.05,"exercise_date":"2025-06-05","expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001493152-24-023209","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315224023209/ownership.xml","form_type":"4"}},{"id":1486204,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2024-06-07T21:39:17.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":7.05,"value":12436.2,"ownership":{"direct":true},"balance_after":10938,"derivative":{"exercise_price":7.05,"exercise_date":"2025-06-05","expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001493152-24-023207","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315224023207/ownership.xml","form_type":"4"}},{"id":1580438,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-03-12T21:53:28.000Z","date":"2024-03-08","kind":"grant","planned":false,"acquired":true,"shares":4893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units subject to vesting whereby 1/3 of the shares subject to the award will vest on the one-year anniversary of March 8, 2025, while the remaining 2/3 of the shares subject to the award will vest semi-annually on a prorated basis over the following two years."}],"balance_after":112311,"source":{"system":"sec-edgar","filing":"0001493152-24-009707","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315224009707/ownership.xml","form_type":"4"}},{"id":1580437,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":71078,"kind":"person","name":"Fogarty Krista","position":1,"cik":"0001906986","reported_name":"Fogarty Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2024-03-12T21:51:12.000Z","date":"2024-03-08","kind":"grant","planned":false,"acquired":true,"shares":991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit subject to vesting whereby 1/3 of the shares subject to the award will vest on the one-year anniversary of March 8, 2025, while the remaining 2/3 of the shares subject to the award will vest semi-annually on a prorated basis over the following two years."}],"balance_after":1727,"source":{"system":"sec-edgar","filing":"0001493152-24-009705","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315224009705/ownership.xml","form_type":"4"}},{"id":1877710,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-05-25T19:10:46.000Z","date":"2023-05-25","kind":"purchase","planned":false,"acquired":true,"shares":8706,"price":5.03,"value":43791.18,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Prior to May 11, 2023, Mr. Patel held 1,678,090 shares of common stock. On May 11, 2023, the Company effected a reverse stock split at a ratio of 1-for17, which resulted in a change in Mr. Patel's shares of common stock to 98,712 as of May 11, 2023."}],"balance_after":107418,"source":{"system":"sec-edgar","filing":"0001493152-23-019050","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315223019050/ownership.xml","form_type":"4"}},{"id":1894732,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":75908,"kind":"person","name":"Papapetropoulos Spyros","position":1,"cik":"0001832694","reported_name":"Papapetropoulos Spyros","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-12T20:37:29.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0.2656,"value":7968.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant."}],"balance_after":62000,"derivative":{"exercise_price":0.2656,"exercise_date":"2024-05-10","expiration_date":"2033-05-10","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-23-016695","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315223016695/ownership.xml","form_type":"4"}},{"id":1894733,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41247,"kind":"person","name":"Higuchi John W.","position":1,"cik":"0001579891","reported_name":"Higuchi John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2023-05-12T20:36:25.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0.2656,"value":7968.0,"ownership":{"direct":true},"balance_after":156000,"derivative":{"exercise_price":0.2656,"exercise_date":"2024-05-10","expiration_date":"2033-05-10","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-23-016692","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315223016692/ownership.xml","form_type":"4"}},{"id":1894731,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2023-05-12T20:35:45.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0.2656,"value":7968.0,"ownership":{"direct":true},"balance_after":166000,"derivative":{"exercise_price":0.2656,"exercise_date":"2024-05-10","expiration_date":"2033-05-10","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-23-016690","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315223016690/ownership.xml","form_type":"4"}},{"id":1894728,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41248,"kind":"person","name":"Jene Jill M.","position":1,"cik":"0001742105","reported_name":"Jene Jill M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-12T20:34:28.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0.2656,"value":7968.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant."}],"balance_after":62000,"derivative":{"exercise_price":0.2656,"exercise_date":"2024-05-10","expiration_date":"2033-05-10","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-23-016685","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315223016685/ownership.xml","form_type":"4"}},{"id":1894730,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2023-05-12T20:33:49.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0.2656,"value":7968.0,"ownership":{"direct":true},"balance_after":166000,"derivative":{"exercise_price":0.2656,"exercise_date":"2024-05-10","expiration_date":"2033-05-10","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-23-016684","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315223016684/ownership.xml","form_type":"4"}},{"id":1938990,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-03-24T21:28:03.000Z","date":"2023-03-24","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":0.32,"value":48000.0,"ownership":{"direct":true},"balance_after":1678090,"source":{"system":"sec-edgar","filing":"0001493152-23-008943","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315223008943/ownership.xml","form_type":"4"}},{"id":1944155,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-20T22:51:33.000Z","date":"2023-03-20","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":0.34,"value":1360.0,"ownership":{"direct":true},"balance_after":14125,"source":{"system":"sec-edgar","filing":"0001493152-23-008304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315223008304/ownership.xml","form_type":"4"}},{"id":1946094,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-03-17T20:31:41.000Z","date":"2023-03-17","kind":"purchase","acquired":true,"shares":50000,"price":0.33,"value":16500.0,"ownership":{"direct":true},"balance_after":1528090,"source":{"system":"sec-edgar","filing":"0001493152-23-008087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315223008087/ownership.xml","form_type":"4"}},{"id":2065970,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-04T17:06:47.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":300000,"price":0.41,"value":123000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 3,2024, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years."}],"balance_after":2542395,"derivative":{"exercise_price":0.41,"exercise_date":"2024-01-03","expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-23-000274","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315223000274/ownership.xml","form_type":"4"}},{"id":2077420,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-23T00:20:50.000Z","date":"2022-12-22","kind":"grant","acquired":true,"shares":112500,"price":0.41,"value":46125.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 22, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years."}],"balance_after":2242395,"derivative":{"exercise_price":0.41,"exercise_date":"2023-12-22","expiration_date":"2032-12-22","underlying":"Common Stock","underlying_shares":112500},"source":{"system":"sec-edgar","filing":"0001493152-22-036373","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222036373/ownership.xml","form_type":"4"}},{"id":2077415,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":71078,"kind":"person","name":"Fogarty Krista","position":1,"cik":"0001906986","reported_name":"Fogarty Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-23T00:18:05.000Z","date":"2022-12-22","kind":"grant","acquired":true,"shares":91850,"price":0.41,"value":37658.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 22, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years."}],"balance_after":229850,"derivative":{"exercise_price":0.41,"exercise_date":"2023-12-22","expiration_date":"2032-12-22","underlying":"Common Stock","underlying_shares":91850},"source":{"system":"sec-edgar","filing":"0001493152-22-036371","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222036371/ownership.xml","form_type":"4"}},{"id":2103173,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":75908,"kind":"person","name":"Papapetropoulos Spyros","position":1,"cik":"0001832694","reported_name":"Papapetropoulos Spyros","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2022-11-28T21:33:12.000Z","date":"2022-11-22","kind":"purchase","acquired":true,"shares":21739,"price":0.47,"value":10217.33,"ownership":{"direct":true},"balance_after":21739,"source":{"system":"sec-edgar","filing":"0001493152-22-033841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222033841/ownership.xml","form_type":"4"}},{"id":2117506,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-11-14T20:58:33.000Z","date":"2022-11-14","kind":"purchase","acquired":true,"shares":75000,"price":0.39,"value":29250.0,"ownership":{"direct":true},"balance_after":1478090,"source":{"system":"sec-edgar","filing":"0001493152-22-031971","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222031971/ownership.xml","form_type":"4"}},{"id":2122024,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":122555,"kind":"person","name":"Nomikos George","position":1,"cik":"0001953799","reported_name":"Nomikos George","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-08T16:57:25.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":125000,"price":0.406,"value":50750.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of November 1, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years."}],"balance_after":125000,"derivative":{"exercise_price":0.406,"exercise_date":"2023-11-01","expiration_date":"2032-11-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001493152-22-030909","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222030909/ownership.xml","form_type":"4"}},{"id":2150407,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-09-27T22:53:05.000Z","date":"2022-09-27","kind":"purchase","acquired":true,"shares":100000,"price":0.41,"value":41000.0,"ownership":{"direct":true},"balance_after":1403090,"source":{"system":"sec-edgar","filing":"0001493152-22-026945","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222026945/ownership.xml","form_type":"4"}},{"id":2235478,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2022-06-10T15:36:00.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":22000,"price":0.92,"value":20240.0,"ownership":{"direct":true},"balance_after":136000,"derivative":{"exercise_price":0.92,"exercise_date":"2023-06-08","expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001493152-22-016406","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222016406/ownership.xml","form_type":"4"}},{"id":2235477,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41247,"kind":"person","name":"Higuchi John W.","position":1,"cik":"0001579891","reported_name":"Higuchi John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2022-06-10T15:35:37.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":22000,"price":0.92,"value":20240.0,"ownership":{"direct":true},"balance_after":307490,"derivative":{"exercise_price":0.92,"exercise_date":"2023-06-08","expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001493152-22-016405","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222016405/ownership.xml","form_type":"4"}},{"id":2235475,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":75908,"kind":"person","name":"Papapetropoulos Spyros","position":1,"cik":"0001832694","reported_name":"Papapetropoulos Spyros","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T15:34:11.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":22000,"price":0.92,"value":20240.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby all of the shares subject to the award will vest on the one year anniversary of June 8, 2023."}],"balance_after":32000,"derivative":{"exercise_price":0.92,"exercise_date":"2023-06-08","expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001493152-22-016402","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222016402/ownership.xml","form_type":"4"}},{"id":2235476,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2022-06-10T15:33:32.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":22000,"price":0.92,"value":20240.0,"ownership":{"direct":true},"balance_after":136000,"derivative":{"exercise_price":0.92,"exercise_date":"2023-06-08","expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001493152-22-016401","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222016401/ownership.xml","form_type":"4"}},{"id":2235474,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41248,"kind":"person","name":"Jene Jill M.","position":1,"cik":"0001742105","reported_name":"Jene Jill M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T15:32:47.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":22000,"price":0.92,"value":20240.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"(1)\t100% vesting one year from date of grant."}],"balance_after":32000,"derivative":{"exercise_price":0.92,"exercise_date":"2023-06-08","expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001493152-22-016399","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222016399/ownership.xml","form_type":"4"}},{"id":2267454,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":71078,"kind":"person","name":"Fogarty Krista","position":1,"cik":"0001906986","reported_name":"Fogarty Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2022-05-17T20:58:58.000Z","date":"2022-05-17","kind":"purchase","acquired":true,"shares":12500,"price":0.86,"value":10750.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001493152-22-014199","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222014199/ownership.xml","form_type":"4"}},{"id":2269860,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-05-16T22:44:41.000Z","date":"2022-05-16","kind":"purchase","acquired":true,"shares":50000,"price":0.7699,"value":38495.0,"ownership":{"direct":true},"balance_after":1303090,"source":{"system":"sec-edgar","filing":"0001493152-22-014014","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222014014/ownership.xml","form_type":"4"}},{"id":2298227,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":75908,"kind":"person","name":"Papapetropoulos Spyros","position":1,"cik":"0001832694","reported_name":"Papapetropoulos Spyros","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-12T21:00:09.000Z","date":"2022-04-11","kind":"grant","acquired":true,"shares":10000,"price":1.16,"value":11600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of April 11, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years."}],"balance_after":10000,"derivative":{"exercise_price":1.16,"exercise_date":"2023-04-11","expiration_date":"2032-04-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-22-009718","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222009718/ownership.xml","form_type":"4"}},{"id":2298226,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41248,"kind":"person","name":"Jene Jill M.","position":1,"cik":"0001742105","reported_name":"Jene Jill M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-12T20:57:54.000Z","date":"2022-04-11","kind":"grant","acquired":true,"shares":10000,"price":1.16,"value":11600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of April 11, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years."}],"balance_after":10000,"derivative":{"exercise_price":1.16,"exercise_date":"2023-04-11","expiration_date":"2032-04-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-22-009716","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222009716/ownership.xml","form_type":"4"}},{"id":2453675,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-03T22:33:10.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":287500,"price":1.09,"value":313375.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 3, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years."}],"balance_after":287500,"derivative":{"exercise_price":1.09,"exercise_date":"2023-01-03","expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":287500},"source":{"system":"sec-edgar","filing":"0001493152-22-000154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222000154/ownership.xml","form_type":"4"}},{"id":2480223,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-08T21:00:25.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":125000,"price":1.12,"value":140000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 7, 2022, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years."}],"balance_after":125000,"derivative":{"exercise_price":1.12,"exercise_date":"2022-12-07","expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001493152-21-030818","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315221030818/ownership.xml","form_type":"4"}},{"id":2480337,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-08T21:00:23.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":176000,"price":1.12,"value":197120.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 7, 2022, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years."}],"balance_after":176000,"derivative":{"exercise_price":1.12,"exercise_date":"2022-12-07","expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":176000},"source":{"system":"sec-edgar","filing":"0001493152-21-030817","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000149315221030817/ownership.xml","form_type":"4"}},{"id":2504398,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-11-19T00:23:09.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":25000,"price":1.09,"value":27250.0,"ownership":{"direct":true},"balance_after":1253090,"source":{"system":"sec-edgar","filing":"0001493152-21-029268","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315221029268/ownership.xml","form_type":"4"}},{"id":2673444,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2021-06-10T18:44:05.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":22000,"price":1.26,"value":27720.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant"}],"balance_after":22000,"derivative":{"exercise_price":1.26,"exercise_date":"2022-06-09","expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001638599-21-000539","document":"doc4_7261.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859921000539/doc4_7261.xml","form_type":"4"}},{"id":2673443,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41247,"kind":"person","name":"Higuchi John W.","position":1,"cik":"0001579891","reported_name":"Higuchi John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2021-06-10T18:43:33.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":22000,"price":1.26,"value":27720.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant"}],"balance_after":22000,"derivative":{"exercise_price":1.26,"exercise_date":"2022-06-09","expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001638599-21-000538","document":"doc4_7260.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859921000538/doc4_7260.xml","form_type":"4"}},{"id":2673442,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T18:42:45.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":22000,"price":1.26,"value":27720.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant"}],"balance_after":22000,"derivative":{"exercise_price":1.26,"exercise_date":"2022-06-09","expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001638599-21-000537","document":"doc4_7259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859921000537/doc4_7259.xml","form_type":"4"}},{"id":2925027,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-05T02:02:38.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":275000,"price":1.43,"value":393250.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 4, 2022, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorata basis over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 4, 2022, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorata basis over the following two years."}],"balance_after":275000,"derivative":{"exercise_price":1.43,"exercise_date":"2022-01-04","expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001638599-21-000014","document":"doc4_6979.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859921000014/doc4_6979.xml","form_type":"4"}},{"id":2925026,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41247,"kind":"person","name":"Higuchi John W.","position":1,"cik":"0001579891","reported_name":"Higuchi John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-04T19:09:06.000Z","date":"2020-12-31","kind":"sale","acquired":false,"shares":5000,"price":1.3534,"value":6767.0,"ownership":{"direct":true},"balance_after":693548,"source":{"system":"sec-edgar","filing":"0001638599-21-000003","document":"doc4_6977.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859921000003/doc4_6977.xml","form_type":"4"}},{"id":2925025,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41247,"kind":"person","name":"Higuchi John W.","position":1,"cik":"0001579891","reported_name":"Higuchi John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-04T19:09:06.000Z","date":"2020-12-31","kind":"sale","acquired":false,"shares":1700,"price":1.345,"value":2286.5,"ownership":{"direct":true},"balance_after":698548,"source":{"system":"sec-edgar","filing":"0001638599-21-000003","document":"doc4_6977.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859921000003/doc4_6977.xml","form_type":"4"}},{"id":2929966,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-29T20:27:43.000Z","date":"2020-12-28","kind":"other","acquired":false,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 15, 2020, the issuer granted to the reporting person, under the issuer's stock incentive plan, options to purchase 375,000 shares of the issuer's common stock.  On December 28, 2020, the issuer rescinded and cancelled 275,000 of the options granted, for no consideration."}],"balance_after":100000,"derivative":{"exercise_price":1.37,"exercise_date":"2021-12-15","expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001638599-20-000995","document":"doc4_6974.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000995/doc4_6974.xml","form_type":"4"}},{"id":2939433,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41247,"kind":"person","name":"Higuchi John W.","position":1,"cik":"0001579891","reported_name":"Higuchi John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-12-17T21:07:44.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."}],"balance_after":3750,"derivative":{"exercise_price":0,"exercise_date":"2020-12-16","expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001638599-20-000981","document":"doc4_6964.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000981/doc4_6964.xml","form_type":"4"}},{"id":2939432,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41247,"kind":"person","name":"Higuchi John W.","position":1,"cik":"0001579891","reported_name":"Higuchi John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-17T21:07:44.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":700248,"source":{"system":"sec-edgar","filing":"0001638599-20-000981","document":"doc4_6964.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000981/doc4_6964.xml","form_type":"4"}},{"id":2939431,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-12-17T21:07:21.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."}],"balance_after":5250,"derivative":{"exercise_price":0,"exercise_date":"2020-12-16","expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":5250},"source":{"system":"sec-edgar","filing":"0001638599-20-000980","document":"doc4_6963.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000980/doc4_6963.xml","form_type":"4"}},{"id":2939430,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-17T21:07:21.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":10125,"source":{"system":"sec-edgar","filing":"0001638599-20-000980","document":"doc4_6963.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000980/doc4_6963.xml","form_type":"4"}},{"id":2939425,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-12-17T21:07:06.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":5625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."}],"balance_after":5625,"derivative":{"exercise_price":0,"exercise_date":"2020-12-16","expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":5625},"source":{"system":"sec-edgar","filing":"0001638599-20-000979","document":"doc4_6962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000979/doc4_6962.xml","form_type":"4"}},{"id":2939424,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-17T21:07:06.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":5625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":6562,"source":{"system":"sec-edgar","filing":"0001638599-20-000979","document":"doc4_6962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000979/doc4_6962.xml","form_type":"4"}},{"id":2939429,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-12-17T21:06:16.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."}],"balance_after":45000,"derivative":{"exercise_price":0,"exercise_date":"2020-12-16","expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001638599-20-000977","document":"doc4_6960.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000977/doc4_6960.xml","form_type":"4"}},{"id":2939428,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-17T21:06:16.000Z","date":"2020-12-15","kind":"grant","acquired":true,"shares":375000,"price":1.37,"value":513750.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 15, 2021, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorata basis over the following two years."}],"balance_after":375000,"derivative":{"exercise_price":1.37,"exercise_date":"2021-12-15","expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001638599-20-000977","document":"doc4_6960.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000977/doc4_6960.xml","form_type":"4"}},{"id":2939427,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-17T21:06:16.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":15000,"price":1.35,"value":20250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":1228090,"source":{"system":"sec-edgar","filing":"0001638599-20-000977","document":"doc4_6960.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000977/doc4_6960.xml","form_type":"4"}},{"id":2939426,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-17T21:06:16.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":1243090,"source":{"system":"sec-edgar","filing":"0001638599-20-000977","document":"doc4_6960.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000977/doc4_6960.xml","form_type":"4"}},{"id":2939772,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Unit","published_at":"2020-12-17T21:05:47.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."}],"balance_after":28125,"derivative":{"exercise_price":0,"exercise_date":"2020-12-16","expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":28125},"source":{"system":"sec-edgar","filing":"0001638599-20-000976","document":"doc4_6959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000976/doc4_6959.xml","form_type":"4"}},{"id":2939771,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-12-17T21:05:47.000Z","date":"2020-12-15","kind":"grant","acquired":true,"shares":160000,"price":1.37,"value":219200.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 15, 2021, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorata basis over the following two years."}],"balance_after":160000,"derivative":{"exercise_price":1.37,"exercise_date":"2021-12-15","expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001638599-20-000976","document":"doc4_6959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000976/doc4_6959.xml","form_type":"4"}},{"id":2939770,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2020-12-17T21:05:47.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":8437,"price":1.35,"value":11389.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":194504,"source":{"system":"sec-edgar","filing":"0001638599-20-000976","document":"doc4_6959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000976/doc4_6959.xml","form_type":"4"}},{"id":2939769,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2020-12-17T21:05:47.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":202941,"source":{"system":"sec-edgar","filing":"0001638599-20-000976","document":"doc4_6959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000976/doc4_6959.xml","form_type":"4"}},{"id":2939764,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-12-17T16:06:44.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."}],"balance_after":7500,"derivative":{"exercise_price":0,"exercise_date":"2020-12-16","expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001638599-20-000978","document":"doc4_6961.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237404/000163859920000978/doc4_6961.xml","form_type":"4"}},{"id":2939763,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-17T16:06:44.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":12750,"source":{"system":"sec-edgar","filing":"0001638599-20-000978","document":"doc4_6961.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237404/000163859920000978/doc4_6961.xml","form_type":"4"}},{"id":2953052,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-12-08T21:50:55.000Z","date":"2020-12-05","kind":"exercise","acquired":false,"shares":122978,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":122978,"derivative":{"exercise_price":0,"exercise_date":"2020-12-05","expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":122978},"source":{"system":"sec-edgar","filing":"0001638599-20-000949","document":"doc4_6948.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000949/doc4_6948.xml","form_type":"4"}},{"id":2953051,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-12-08T21:50:55.000Z","date":"2020-12-04","kind":"exercise","acquired":false,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to vesting whereby 50% of the shares subject to the award will vest on the one year anniversary of December 4, 2019 and the remaining 50% of the shares subject to the award will vest on the two year anniversary of December 4, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to vesting whereby 50% of the shares subject to the award will vest on the one year anniversary of December 4, 2019 and the remaining 50% of the shares subject to the award will vest on the two year anniversary of December 4, 2020."}],"balance_after":145000,"derivative":{"exercise_price":0,"exercise_date":"2020-12-04","expiration_date":"2028-12-04","underlying":"Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001638599-20-000949","document":"doc4_6948.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000949/doc4_6948.xml","form_type":"4"}},{"id":2953050,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-08T21:50:55.000Z","date":"2020-12-05","kind":"exercise","acquired":true,"shares":122978,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":1198090,"source":{"system":"sec-edgar","filing":"0001638599-20-000949","document":"doc4_6948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000949/doc4_6948.xml","form_type":"4"}},{"id":2953049,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-08T21:50:55.000Z","date":"2020-12-04","kind":"sale","acquired":false,"shares":43500,"price":1.5663,"value":68134.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price of shares sold at a price that ranged from $1.53 - $1.60"}],"balance_after":1075112,"source":{"system":"sec-edgar","filing":"0001638599-20-000949","document":"doc4_6948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000949/doc4_6948.xml","form_type":"4"}},{"id":2953048,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-08T21:50:55.000Z","date":"2020-12-04","kind":"exercise","acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":1118612,"source":{"system":"sec-edgar","filing":"0001638599-20-000949","document":"doc4_6948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000949/doc4_6948.xml","form_type":"4"}},{"id":2953206,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-12-08T21:50:36.000Z","date":"2020-12-05","kind":"exercise","acquired":false,"shares":70754,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":70754,"derivative":{"exercise_price":0,"exercise_date":"2020-12-05","expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":70754},"source":{"system":"sec-edgar","filing":"0001638599-20-000948","document":"doc4_6947.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000948/doc4_6947.xml","form_type":"4"}},{"id":2953205,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-12-08T21:50:36.000Z","date":"2020-12-04","kind":"exercise","acquired":false,"shares":57500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to vesting whereby 50% of the shares subject to the award will vest on the one year anniversary of December 4, 2019 and the remaining 50% of the shares subject to the award will vest on the two year anniversary of December 4, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to vesting whereby 50% of the shares subject to the award will vest on the one year anniversary of December 4, 2019 and the remaining 50% of the shares subject to the award will vest on the two year anniversary of December 4, 2020."}],"balance_after":57500,"derivative":{"exercise_price":0,"exercise_date":"2020-12-04","expiration_date":"2028-12-04","underlying":"Common Stock","underlying_shares":57500},"source":{"system":"sec-edgar","filing":"0001638599-20-000948","document":"doc4_6947.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000948/doc4_6947.xml","form_type":"4"}},{"id":2953204,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-08T21:50:36.000Z","date":"2020-12-05","kind":"exercise","acquired":true,"shares":70754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":174816,"source":{"system":"sec-edgar","filing":"0001638599-20-000948","document":"doc4_6947.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000948/doc4_6947.xml","form_type":"4"}},{"id":2953203,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-08T21:50:36.000Z","date":"2020-12-04","kind":"sale","acquired":false,"shares":17250,"price":1.5666,"value":27023.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price of shares sold at a price that ranged from $1.54 - $1.60."}],"balance_after":104062,"source":{"system":"sec-edgar","filing":"0001638599-20-000948","document":"doc4_6947.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000948/doc4_6947.xml","form_type":"4"}},{"id":2953202,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-08T21:50:36.000Z","date":"2020-12-04","kind":"exercise","acquired":true,"shares":57500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":121312,"source":{"system":"sec-edgar","filing":"0001638599-20-000948","document":"doc4_6947.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000948/doc4_6947.xml","form_type":"4"}},{"id":3114376,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41247,"kind":"person","name":"Higuchi John W.","position":1,"cik":"0001579891","reported_name":"Higuchi John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-10T20:11:55.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":22000,"price":0.9629,"value":21183.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant"}],"balance_after":22000,"derivative":{"exercise_price":0.9629,"exercise_date":"2021-06-10","expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001638599-20-000594","document":"doc4_6750.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000594/doc4_6750.xml","form_type":"4"}},{"id":3114377,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-10T20:11:11.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":22000,"price":0.9629,"value":21183.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant"}],"balance_after":22000,"derivative":{"exercise_price":0.9629,"exercise_date":"2021-06-10","expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001638599-20-000592","document":"doc4_6752.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000592/doc4_6752.xml","form_type":"4"}},{"id":3114373,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-10T20:10:43.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":22000,"price":0.9629,"value":21183.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant"}],"balance_after":22000,"derivative":{"exercise_price":0.9629,"exercise_date":"2021-06-10","expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001638599-20-000591","document":"doc4_6753.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000591/doc4_6753.xml","form_type":"4"}},{"id":3114482,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2020-06-10T16:11:33.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":22000,"price":0.9629,"value":21183.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant"}],"balance_after":22000,"derivative":{"exercise_price":0.9629,"exercise_date":"2021-06-10","expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001638599-20-000593","document":"doc4_6751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237404/000163859920000593/doc4_6751.xml","form_type":"4"}},{"id":3201916,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41247,"kind":"person","name":"Higuchi John W.","position":1,"cik":"0001579891","reported_name":"Higuchi John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-18T15:20:17.000Z","date":"2020-03-17","kind":"purchase","acquired":true,"shares":220000,"price":0.3161,"value":69542.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the average price of shares purchased at prices that ranged from $0.3111 - $0.328."}],"balance_after":696498,"source":{"system":"sec-edgar","filing":"0001638599-20-000313","document":"doc4_6603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000313/doc4_6603.xml","form_type":"4"}},{"id":3300034,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-28T21:26:54.000Z","date":"2020-01-28","kind":"grant","acquired":true,"shares":132000,"price":0.458,"value":60456.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 28, 2021, while the remaining 2/3 of the shares subject to the award vest monthly on a prorata basis over the following two years."}],"balance_after":132000,"derivative":{"exercise_price":0.458,"exercise_date":"2021-01-28","expiration_date":"2030-01-28","underlying":"Common Stock","underlying_shares":132000},"source":{"system":"sec-edgar","filing":"0001638599-20-000106","document":"doc4_6488.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000106/doc4_6488.xml","form_type":"4"}},{"id":3299885,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-28T21:26:34.000Z","date":"2020-01-28","kind":"grant","acquired":true,"shares":300000,"price":0.458,"value":137400.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 28, 2021, while the remaining 2/3 of the shares subject to the award vest monthly on a prorata basis over the following two years."}],"balance_after":300000,"derivative":{"exercise_price":0.458,"exercise_date":"2021-01-28","expiration_date":"2030-01-28","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001638599-20-000105","document":"doc4_6489.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000105/doc4_6489.xml","form_type":"4"}}],"next_cursor":"2020-01-28T21:26:34.000000Z,3299885"}